Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125213392 | 12521339 | 2 | F | 20160630 | 20160701 | 20160714 | EXP | US-ACORDA-ACO_123778_2016 | ACORDA | 0.00 | F | Y | 0.00000 | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125213392 | 12521339 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, BID | 0000079809 | 22250 | 10 | MG | TABLET | BID | |||||
| 125213392 | 12521339 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | 22250 | TABLET | |||||||||||
| 125213392 | 12521339 | 3 | C | VITAMIN D | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 4 | C | Senna Maximum Strength | 2 | U | 0 | ||||||||||||
| 125213392 | 12521339 | 5 | C | PAMELOR | NORTRIPTYLINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 6 | C | ESTRACE | ESTRADIOL | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 7 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 8 | C | Calcium Citrate + D | 2 | U | 0 | ||||||||||||
| 125213392 | 12521339 | 9 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 10 | C | TYSABRI | NATALIZUMAB | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 11 | C | BACLOFEN. | BACLOFEN | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 12 | C | Vitamin B-12 CR | 2 | U | 0 | ||||||||||||
| 125213392 | 12521339 | 13 | C | MELOXICAM. | MELOXICAM | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 14 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125213392 | 12521339 | 15 | C | Methadone hcl | METHADONE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125213392 | 12521339 | 1 | Multiple sclerosis |
| 125213392 | 12521339 | 2 | Gait disturbance |
| 125213392 | 12521339 | 3 | Product used for unknown indication |
| 125213392 | 12521339 | 4 | Product used for unknown indication |
| 125213392 | 12521339 | 5 | Product used for unknown indication |
| 125213392 | 12521339 | 6 | Product used for unknown indication |
| 125213392 | 12521339 | 7 | Product used for unknown indication |
| 125213392 | 12521339 | 8 | Product used for unknown indication |
| 125213392 | 12521339 | 9 | Product used for unknown indication |
| 125213392 | 12521339 | 10 | Product used for unknown indication |
| 125213392 | 12521339 | 11 | Product used for unknown indication |
| 125213392 | 12521339 | 12 | Product used for unknown indication |
| 125213392 | 12521339 | 13 | Product used for unknown indication |
| 125213392 | 12521339 | 14 | Product used for unknown indication |
| 125213392 | 12521339 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125213392 | 12521339 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125213392 | 12521339 | Condition aggravated | |
| 125213392 | 12521339 | Intervertebral disc disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125213392 | 12521339 | 1 | 2011 | 0 |